Prevail Therapeutics Q3 EPS $(0.62) Up From $(0.99) YoY

Prevail Therapeutics (NASDAQ:PRVL) reported quarterly losses of $(0.62) per share. This is a 37.37 percent increase over losses of $(0.99) per share from the same period last year.

Benzinga · 11/12/2019 14:30

Prevail Therapeutics (NASDAQ:PRVL) reported quarterly losses of $(0.62) per share. This is a 37.37 percent increase over losses of $(0.99) per share from the same period last year.